Last Updated: 05/02/2025
P. vivax serological testing & treatment: a novel intervention to facilitate malaria elimination (SeroTAT)
Objectives
To develop the diagnostic tools and clinical trials evidence to prove that a new public health intervention, Plasmodium vivax Serological Test and Treat (SeroTAT) can facilitate P. vivax elimination in vivax endemic countries world-wide.
Principal Institution
Walter and Eliza Hall Institute of Medical Research (WEHI), Australia
Principal Investigators / Focal Persons
Rationale and Abstract
To achieve the objective, a new class of malaria point-of-care sero-diagnostic test will be developed that can identify those most at risk of recurrent vivax malaria, and prove that treating these people will significantly reduce P. vivax transmission.
External reference
Thematic Categories
Date
Oct 2022 — Dec 2027
Total Project Funding
$1.6M
Funding Details
National Health and Medical Research Council (NHMRC) Australia, Australia
Grant ID: GA271308
AUD 2.47M
Project Site
Related Resources
